Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Effects of hemodialysis dose and membrane flux on health-related quality of life in the HEMO Study.

Unruh M, Benz R, Greene T, Yan G, Beddhu S, DeVita M, Dwyer JT, Kimmel PL, Kusek JW, Martin A, Rehm-McGillicuddy J, Teehan BP, Meyer KB; HEMO Study Group.

Kidney Int. 2004 Jul;66(1):355-66.

2.

Effect of dialysis dose and membrane flux in maintenance hemodialysis.

Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R; Hemodialysis (HEMO) Study Group.

N Engl J Med. 2002 Dec 19;347(25):2010-9.

3.

Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients.

Cheung AK, Sarnak MJ, Yan G, Dwyer JT, Heyka RJ, Rocco MV, Teehan BP, Levey AS.

Kidney Int. 2000 Jul;58(1):353-62.

4.

Continuous renal replacement therapies: an update.

Manns M, Sigler MH, Teehan BP.

Am J Kidney Dis. 1998 Aug;32(2):185-207. Review.

PMID:
9708602
5.

Intradialytic renal haemodynamics--potential consequences for the management of the patient with acute renal failure.

Manns M, Sigler MH, Teehan BP.

Nephrol Dial Transplant. 1997 May;12(5):870-2. Review. No abstract available.

PMID:
9175035
6.

Peritoneal dialysis: an evolving understanding.

McCusker FX, Teehan BP.

Semin Nephrol. 1997 May;17(3):226-38. Review.

PMID:
9165652
7.

NIH Peritoneal Dialysis Workshop Nutrition Subcommittee: research recommendations.

Teehan BP, Churchill DN, Kopple JD, Kohaul EC.

Perit Dial Int. 1997;17 Suppl 3:S58-9. No abstract available.

PMID:
9304663
8.

How much peritoneal dialysis is required for the maintenance of a good nutritional state? Canada-USA (CANUSA) Peritoneal Dialysis Study Group.

McCusker FX, Teehan BP, Thorpe KE, Keshaviah PR, Churchill DN.

Kidney Int Suppl. 1996 Nov;56:S56-61. No abstract available.

PMID:
8914055
9.

A proposed glossary for dialysis kinetics.

Kopple JD, Jones MR, Keshaviah PR, Bergström J, Lindsay RM, Moran J, Nolph KD, Teehan BP.

Am J Kidney Dis. 1995 Dec;26(6):963-81.

PMID:
7503074
10.

Continuous ambulatory peritoneal dialysis--quo vadis?

Teehan BP, Hakim R.

J Am Soc Nephrol. 1995 Aug;6(2):139-43. No abstract available.

11.

Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients.

Revicki DA, Brown RE, Feeny DH, Henry D, Teehan BP, Rudnick MR, Benz RL.

Am J Kidney Dis. 1995 Apr;25(4):548-54.

PMID:
7702049
12.

Adequacy of continuous ambulatory peritoneal dialysis: morbidity and mortality in chronic peritoneal dialysis.

Teehan BP, Schleifer CR, Brown J.

Am J Kidney Dis. 1994 Dec;24(6):990-101. Review.

PMID:
7985681
13.

Recommendations for reducing the high morbidity and mortality of United States maintenance dialysis patients. The National Kidney Foundation.

Kopple JD, Hakim RM, Held PJ, Keane WF, King K, Lazarus JM, Parker TF 3rd, Teehan BP.

Am J Kidney Dis. 1994 Dec;24(6):968-73. No abstract available.

PMID:
7985678
14.

Assessment of dialysis adequacy and nutrition by urea kinetic modeling.

Teehan BP, Schleifer CR, Brown J.

Perit Dial Int. 1994;14 Suppl 3:S99-104. Review. No abstract available.

PMID:
7948286
15.
16.

Suppression of renal vein renin profiles by mannitol prophylaxis: implications in the evaluation of renovascular hypertension.

Benz RL, Teehan BP, Sigler MH, Gilgore GS, Schleifer CR.

Am J Kidney Dis. 1991 Dec;18(6):649-54.

PMID:
1962648
17.

Intradialytic parenteral nutrition in chronic hemodialysis patients.

Snyder S, Bergen C, Sigler MH, Teehan BP.

ASAIO Trans. 1991 Jul-Sep;37(3):M373-5.

PMID:
1751194
18.

Early intervention with recombinant human erythropoietin therapy.

Teehan BP, Benz RL, Sigler MH, Brown JM.

Semin Nephrol. 1990 Mar;10(2 Suppl 1):28-34. No abstract available.

PMID:
2192414
19.

Urea kinetic analysis and clinical outcome on CAPD. A five year longitudinal study.

Teehan BP, Schleifer CR, Brown JM, Sigler MH, Raimondo J.

Adv Perit Dial. 1990;6:181-5.

PMID:
1982804
20.

Successful treatment of postparathyroidectomy hypocalcemia using continuous ambulatory intraperitoneal calcium (CAIC) therapy.

Benz RL, Schleifer CR, Teehan BP, Sigler MH, Gilgore GS.

Perit Dial Int. 1989;9(4):285-8.

PMID:
2488383
21.
22.
23.

Suprofen and renal failure.

Snyder S, Teehan BP.

Ann Intern Med. 1987 May;106(5):776. No abstract available.

PMID:
3565984
24.

Acetate and energy metabolism during hemodialysis.

Sigler MH, Skutches CL, Teehan BP, Cooper JH, Reichard GA.

Kidney Int Suppl. 1983 Dec;16:S97-101.

PMID:
6429408
25.

Effects of dialysis prescription on bone and mineral metabolism: the National Cooperative Dialysis Study.

Harter HR, Laird NM, Teehan BP.

Kidney Int Suppl. 1983 Apr;(13):S73-9. No abstract available.

PMID:
6345900
26.

Influences of dialysis prescription on electrolyte and acid-base metabolism: the National Cooperative Dialysis Study.

Teehan BP, Laird NM, Harter HR.

Kidney Int Suppl. 1983 Apr;(13):S66-72. No abstract available.

PMID:
6345899
27.

Principles of prescribing dialysis therapy: implementing recommendations from the National Cooperative Dialysis Study.

Lowrie EG, Teehan BP.

Kidney Int Suppl. 1983 Apr;(13):S113-22. No abstract available.

PMID:
6345893
28.

Contribution of dialysate acetate to energy metabolism: metabolic implications.

Skutches CL, Sigler MH, Teehan BP, Cooper JH, Reichard GA.

Kidney Int. 1983 Jan;23(1):57-63.

29.

Acid-base balance in continuous ambulatory peritoneal dialysis.

Schleifer CR, Teehan BP, Reichard GA, Sigler MH, Cupit M, Haff AC.

Proc Clin Dial Transplant Forum. 1980;10:100-4.

PMID:
7346838
30.

Plasma pyridoxal-5'-phosphate levels and clinical correlations in chronic hemodialysis patients.

Teehan BP, Smith LJ, Sigler MH, Gilgore GS, Schleifer CR.

Am J Clin Nutr. 1978 Oct;31(10):1932-6.

PMID:
707350
31.

Resorcinol-induced hypothydroidism in a patient on chronic hemodialysis.

Katin MJ, Teehan BP, Sigler MH, Schleifer CR, Gilgere GS.

Ann Intern Med. 1977 Apr;86(4):447-9. No abstract available.

PMID:
848809
32.

A clinical appraisal of the dialysis index.

Teehan BP, Gacek EM, Heymach GJ, Brown J, Smith LJ, Sigler MH, Gilgore GS, Schleifer CR.

Trans Am Soc Artif Intern Organs. 1977;23:548-55. No abstract available.

PMID:
910380
33.

Functional and morphological changes in refused Gambro-Lundia Nova dialyzers.

Teehan BP, Smith LJ, Hartigan MF, Griesemer GA, Gilgore GS, Sigler MH.

Proc Clin Dial Transplant Forum. 1975 Nov;5:51-7. No abstract available.

PMID:
785463
34.

Adverse effects of large surface area dialysis on motor nerve conduction velocity.

Teehan BP, Smith LJ, Gilgore GS, Sigler MH.

Proc Clin Dial Transplant Forum. 1974;(4):166-71. No abstract available.

PMID:
4468415
35.

Steroid-resistant idiopathic nephrotic syndrome. Results of azathioprine treatment in adults.

Teehan BP, Argy WP Jr, Schreiner GE.

Arch Intern Med. 1972 Dec;130(6):877-82. No abstract available.

PMID:
5082468
36.

Dialysis of poisons and drugs - annual review.

Schreiner GE, Teehan BP.

Trans Am Soc Artif Intern Organs. 1972;18(0):563-99. Review. No abstract available.

PMID:
4610970
37.

Dialysis of poisons and drugs--annual review.

Schreiner GE, Teehan BP.

Trans Am Soc Artif Intern Organs. 1971;17:513-44. Review. No abstract available.

PMID:
4945711
38.

Acute ethchlorvynol (Placidyl) intoxication.

Teehan BP, Maher JF, Carey JJ, Flynn PD, Schreiner GE.

Ann Intern Med. 1970 Jun;72(6):875-82. No abstract available.

PMID:
4317667

Supplemental Content

Loading ...
Support Center